RXQ Lidocaine-Epinephrine Solution Recall: Subpotent Drug Risk
RXQ Compounding LLC recalls Lidocaine 1% + Epinephrine 1:100,000 injection solution due to subpotent drug testing. This affects specific vials with NDC 7073197450, lot 04042018:58, expiring 10/17/18.
Lower-risk recall
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Contact the company
What happened, in plain English
RXQ Compounding LLC is recalling Lidocaine 1% + Epinephrine 1:100,000 injection solution because testing showed it's subpotent. This means the medication may not work as intended when used for medical purposes. Read more at govinfonow.com/recall/39551-rxq-lidocaine-epinephrine-solution-recall-subpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39551-rxq-lidocaine-epinephrine-solution-recall-subpotent-drug-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-0130-2019
Cite this page
“RXQ Lidocaine-Epinephrine Solution Recall: Subpotent Drug Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39551-rxq-lidocaine-epinephrine-solution-recall-subpotent-drug-risk. Based on FDA recall #D-0130-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0130-2019%22&limit=1).
Why it’s dangerous
The product was found to be subpotent during testing, meaning it contains less active medication than it should. This could lead to the medication not working effectively during medical procedures. However, the risk is not immediate or life-threatening.
Who’s affected
Prescription users who received this specific injection solution from RXQ Compounding LLC. Healthcare providers and patients using the product for medical procedures are most at risk.
How to tell if you have this one
Check for the product name 'Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL', 50 mL vials, with NDC 7073197450 and lot number 04042018:58. The expiration date is 10/17/18.
- Brand
RXQ Compounding LLC- Category
Drug
What to do — step by step
Check Product Details
Verify the NDC number 7073197450 and lot number 04042018:58 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4.1 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0130-2019 (September 25, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0130-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.